1Lehner R,Lucia MS,Jarboe EA,et al.Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.Appl Immunohistochem Mol Morphol,2002,10(2) :134 - 138.
2Sharp JD,Hausladen DA,Maher MG,et al.Bladder cancer detection with urinary survivin,an inhibitor of apoptosis.Front Biosci,2002,7:e36 -41.
3Smith SD,Wheeler MA,Plescia J,et al.Urine detection of survivin and diagnosis of bladder cancer.JAMA,2001,285 (3) :324 - 328.
4Wu Y ,Wang G ,Wei J ,et al.Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.Indian J Med Sci,2005,59 (6) :235 - 42.
5Lokeshwar VB,Block NL.HA - HAase urine test:a sensitive and specific method for detecting bladder cancer and evaluating its grade.Urol Clin North Am,2000,27 (1) :53 - 61.
6Hautmannn SH,Lokeshwar VB,Schroeder GL,et al.Elevated tissue expression of hyaluronic acid and hyaluronidese validates the HA-HAase urine test for bladder cancer.J Urol,2001,165 (6pt1) :2068 -2074.
7Ho SM,Cheng RY.A promising bladder cancer detection assay:the HA - HAase test.J Urol,2004,172 (3):824 - 825.
8Ross JS,Cohen MB.Biomarkers for the detection of bladder cancer.Adv Anat Pathol,2001,8 (1) :37 -45.
9Zippe C,Pandrangi L,Agarwal A.NMP22 is a sensitive,cost- effective test in patients at risk for bladder cancer.J Urol,1999,161 (1):62 - 65.
10Sharma S,Zippe CD,Pandrangi L,et al.Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat.J Urol,1999,162(1) :53 -57.
